Search Within

David R D'Adamo

  1. "Body Imaging Service"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
Groups
  1. Body Imaging Service (6)
  2. Radiology, Department of (6)
  3. Department of Medicine (5)
  4. Solid Tumor Oncology Division (5)
  5. Biostatistics Service (3)
  6. Department of Pathology and Laboratory Medicine (3)

More Groups

People
  1. Gary Schwartz (4)
  2. Cristina Antonescu (3)
  3. Lawrence Schwartz (3)
  4. Mary Keohan (3)
  5. Robert Maki (3)
  6. David Ilson (2)

More People

Years
  1. 2011 (2)
  2. 2009 (2)
  3. 2006 (1)
  4. 2005 (1)
Publications
  1. Journal of Clinical Oncology (4)
  2. Clinical Cancer Research (1)
  3. Urologia Internationalis (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. American Association for Cancer Research (1)
  3. S. Karger AG (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of sorafenib (S) and dacarbazine (D) in leiomyosarcoma (LMS), synovial sarcoma (SS), and malignant peripheral nerve sheath tumor (MPNST)
    Meeting Abstract

    D'Adamo, D. R.; Keohan, M. L.; Carvajal, R. D.; Hensley, M. L.; Hirst, C.; Qin, L.; Antonescu, C.; Lefkowitz, R. A.; Schwartz, G. K.; Maki, R. G.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Activity of sorafenib against desmoid tumor/deep fibromatosis
    Journal Article

    Gounder, M. M.; Lefkowitz, R. A.; Keohan, M. L.; D'adamo, D. R.; Hameed, M.; Antonescu, C. R.; Singer, S.; Stout, K.; Ahn, L.; Maki, R. G.
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Phase II study of sorafenib in patients with metastatic or recurrent sarcomas
    Journal Article

    Maki, R. G.; D'adamo, D. R.; Keohan, M. L.; Saulle, M.; Schuetze, S. M.; Undevia, S. D.; Livingston, M. B.; Cooney, M. M.; Hensley, M. L.; Mita, M. M.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Pure primary prostatic osteosarcoma arising in a non-irradiated prostate
    Journal Article

    Rabbani, F.; Fine, R. G.; D'adamo, D.; Edgar, M.; Akin, O.; Paty, P.
    Urologia Internationalis (2009)

    Fulltext@MSK | Save
  • Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinorna
    Journal Article

    Shah, M. A.; Ramanathan, R. K.; Ilson, D. H.; Levnor, A.; D'adamo, D.; O'reilly, E.; Tse, A.; Trocola, R.; Schwartz, L.; Capanu, M.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • A multicenter phase II study of irinotecan (CPT), cisplatin (CIS), and bevacizumab (BEV) in patients with unresectable or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma
    Meeting Abstract

    Shah, M. A.; Ilson, D.; Ramanathan, R. K.; Levner, A.; D'adamo, D.; Schwartz, L.; Casper, E.; Schwartz, G. K.; Kelsen, D. P.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save